In accordance with the applicable requirements and regulations of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and other applicable Regulations, Eris Lifesciences has informed that it enclosed the schedule of Analyst / Institutional Investor Meetings scheduled on April 05, 2023. Company will be referring to publicly available documents for discussions during interaction in the meetings and no unpublished price sensitive information (UPSI) is intended to be discussed during the interaction.
The above information is a part of company’s filings submitted to BSE.
